Intellectus Partners, LLC Novartis Ag Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Intellectus Partners, LLC holds 4,261 shares of NVS stock, worth $422,265. This represents 0.13% of its overall portfolio holdings.

Number of Shares

4,261

Previous 4,342 1.87%

Holding current value

$422,265

Previous $462,000 6.06%

% of portfolio

0.13%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$106.13 - $120.89 $8,596 - $9,792	-81 Reduced 1.87%	4,261 $490,000
Q2 2024 Jul 18, 2024	SELL	$92.57 - $107.37 $35,546 - $41,230	-384 Reduced 8.13%	4,342 $462,000
Q2 2023 Jul 31, 2023	SELL	$92.52 - $104.91 $154,045 - $174,675	-1,665 Reduced 26.05%	4,726 $476,000
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $12,564 - $14,571	-157 Reduced 2.4%	6,391 $587,000
Q4 2022 Feb 02, 2023	BUY	$75.55 - $92.52 $66,408 - $81,325	879 Added 15.51%	6,548 $594,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $28,423 - $33,093	-353 Reduced 5.86%	5,669 $479,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $1,602 - $1,812	20 Added 0.33%	6,022 $528,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $5,579 - $6,169	-70 Reduced 1.15%	6,002 $524,000
Q3 2021 Nov 16, 2021	SELL	$81.78 - $95.14 $81 - $95	-1 Reduced 0.02%	6,072 $497,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $596 - $659	-7 Reduced 0.12%	6,073 $554,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $4,258 - $5,021	-51 Reduced 0.83%	6,080 $520,000
Q4 2020 Feb 18, 2021	BUY	$78.07 - $94.43 $408,384 - $493,963	5,231 Added 581.22%	6,131 $579,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $417,128 - $504,539	-5,343 Reduced 85.58%	900 $579,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $45,012 - $49,868	-548 Reduced 8.07%	6,243 $543,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $75,051 - $105,148	1,062 Added 18.54%	6,791 $560,000
Q3 2019 Oct 11, 2019	SELL	$85.54 - $94.26 $48,928 - $53,916	-572 Reduced 9.08%	5,729 $498,000
Q2 2019 Aug 08, 2019	BUY	$75.4 - $92.8 $161,582 - $198,870	2,143 Added 51.54%	6,301 $575,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $68,724 - $76,524	933 Added 28.93%	4,158 $357,000
Q3 2018 Nov 15, 2018	BUY	$66.94 - $77.43 $22,491 - $26,016	336 Added 11.63%	3,225 $278,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $3,245 - $3,668	-50 Reduced 1.7%	2,889 $218,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $13,022 - $15,567	-185 Reduced 5.92%	2,939 $246,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $70,951 - $73,947	-957 Reduced 23.45%	3,124 $268,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,081	4,081 $341,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Novartis Ag Transaction History